The Subject Expert Committee on COVID-19 examined the data and deliberated on the EUA application on Monday.
The firm presented that Sputnik Light vaccine is approved in 29 countries, including Russia and Argentina.
Individual scientists attached to research institutions and domestic companies like Lupin, Dr Reddy's and Cadila account for the rest.
Drug firm Nicholas Piramal India Ltd said on Thursday it plans to invest about $50 million (about Rs 2.25 billion) in the next two years for developing and manufacturing formulations in the UK and India.
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it expected to get US approvals for a paediatric dosage of its generic version of Augmentin, GlaxoSmithKline's blockbuster antibiotic, within a month.\n\n\n\n
With its slick cinematography and breathless pace, Bloody Daddy is not really made for OTT, but that's where it ends up, notes Deepa Gahlot.
India's drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines.
An expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage just two days ago, officials said.
A threatening message was left for Lionel Messi at a supermarket belonging to the family of Antonela Roccuzzo, the Argentine captain's wife.
With India slowly but steadily morphing into a global pharmaceutical R&D hub, scientists have run into short supply.
The consignment was imported by a trading company registered in Vijaywada in Andhra Pradesh.
Hamied however, will continue to be the Vice- Chairman of the company in a non-executive role effective April 1
The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.
According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.
Clubbing in multiple weddings in one go dilutes some of the conversation. Conflicts are resolved too neatly and grey areas of complicated equations are left on a note of ambiguity, observes Sukanya Verma after watching the second season of Made in Heaven.
The Hyderabad-based firm completed clinical trials of the nasal vaccine with about 4,000 volunteers and there is no side effect or adverse reaction reported so far, company sources had said.
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.
.jpg)
As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.
Besides Aryan Khan, the arrested accused are identified as Munmun Dhamecha, Arbaaz Merchant, Ismeet Singh, Mohak Jaswal, Gomit Chopra, Nupur Sarika, and Vikrant Chhokar.
Thackeray, whose Maha Vikas Aghadi government fell after a rebellion in June last year by his cabinet colleague Eknath Shinde, who went on to become CM, also warned he would extract revenge for his ouster.
In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.
'Enterprises have become more demanding in terms of their productivity expectation from their employees.'
Maharashtra govt, California-based Zipline to launch the automated delivery service funded by Serum Institute.
Fortune seekers in the Indian pharmaceutical space will find this irresistible. In less than 24 months, 26 blockbuster medicines, worth over $69 billion (about Rs 3,10,000 crore) -- or thrice the size of the domestic industry -- are going off-patent in the world's largest drug market, the United States.
The papers noted that the 5G network is built on easily accessible and open Internet protocols and it inherits all the vulnerabilities of previous generations which make it vulnerable to cyber-attacks and compromising the security of the entire system.
Testers were also routinely obstructed from gaining access to athletes who used military cities as the location for their whereabouts knowing doping control officers would need special permission to gain access. The WADA update also revealed several examples of widespread efforts to avoid testing, including one detailed instance where an athlete tried to use a container inserted inside her body that presumably contained clean urine.
On Saturday, an online marijuana sale racket was busted by Bhind police in Madhya Pradesh, leading to the arrest of two persons and seizure of 20 kilograms of the contraband, according to an official. The accused were operating the racket through a leading e-commerce firm, which received two-thirds of the profits generated, as per the official.
The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.
Dr Reddy's Laboratories, Nicholas Piramal and other Indian drug makers are relying on niche and smaller value, acquisition strategy for growth owing to global slowdown and failure of big-ticket acquisitions in the past.
Himalaya Drug Company said on Tuesday that it is setting up a Rs 165 crore (Rs 1.65 billion) research and development and manufacturing unit on the outskirts of Bangalore to be completed by 2005.
The transaction is expected to be closed in the first quarter of the financial year.
In a statement Bharat Biotech clarified that the vaccine's efficacy can only be determined 14 days after the second dose.
Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.
The NCB also found some documents and some material, suspected to be drugs, after an over six-hour-long search onboard the ship, the official said, without divulging any further details.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances